{"id":700,"date":"2017-10-31T11:51:47","date_gmt":"2017-10-31T11:51:47","guid":{"rendered":"http:\/\/neuroeconomix.com\/?p=700"},"modified":"2025-01-28T18:21:59","modified_gmt":"2025-01-28T23:21:59","slug":"esta-en-riesgo-de-caer-en-la-lista-de-exclusiones-aqui-le-contamos","status":"publish","type":"post","link":"https:\/\/neuroeconomix.com\/en\/esta-en-riesgo-de-caer-en-la-lista-de-exclusiones-aqui-le-contamos\/","title":{"rendered":"\u00bfEst\u00e1 en riesgo de caer en la lista de exclusiones? Aqu\u00ed le contamos"},"content":{"rendered":"<p>[vc_row css=\u00bb.vc_custom_1533834763111{background-color: #ffffff !important;}\u00bb][vc_column][vc_custom_heading text=\u00bb\u00bfEst\u00e1 en riesgo de caer en la lista de exclusiones? Aqu\u00ed le contamos\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_row_inner content_placement=\u00bbmiddle\u00bb][vc_column_inner width=\u00bb1\/4&#8243;][\/vc_column_inner][vc_column_inner width=\u00bb1\/4&#8243;][vc_single_image image=\u00bb1869&#8243; img_size=\u00bb110&#215;110&#8243; alignment=\u00bbcenter\u00bb style=\u00bbvc_box_shadow_circle_2&#8243; css_animation=\u00bbbounceIn\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/4&#8243;][vc_column_text el_class=\u00bbreferencias\u00bb]<strong>Por:\u00a0<\/strong><strong>Fabian Hern\u00e1ndez<\/strong><br \/>\nQu\u00edmico Farmac\u00e9utico<br \/>\nInvestigador en Econom\u00eda de la Salud<br \/>\nNeuroeconomix[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/4&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]De acuerdo con la Ley Estatutaria en Salud (Ley 1751) que aval\u00f3 la Corte Constitucional en 2015, se defini\u00f3 un <span style=\"color: #ffbf00;\"><strong>marco para el derecho fundamental a la salud<\/strong><\/span>, por medio de un <span style=\"color: #ffbf00;\"><strong>mecanismo que busca la asignaci\u00f3n adecuada de recursos.<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Es decir, que el sistema de salud no podr\u00e1 financiar servicios y tecnolog\u00edas que:<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>Tengan un fin primordialmente cosm\u00e9tico<\/li>\n<li>Carezcan de evidencia sobre eficacia, seguridad y efectividad cl\u00ednica<\/li>\n<li>No est\u00e9n autorizados para su uso en el pa\u00eds<\/li>\n<li>Sean experimentales o tengan que ser prestados en el exterior<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>La lista de tecnolog\u00edas que cumplen alguno de estos criterios tambi\u00e9n es conocida como <span style=\"color: #ffbf00;\"><strong><em>lista de exclusiones.<\/em><\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Si bien el cumplimiento de los criterios lo realiza un grupo de an\u00e1lisis t\u00e9cnico-cient\u00edfico conformado por el IETS, aqu\u00ed le presentamos los puntos clave que tiene en cuenta este grupo para analizar y decidir, si nomina o no, una tecnolog\u00eda a la lista de exclusiones:<\/p>\n<p><span style=\"color: #9b0707;\"><strong>1. Que tengan un fin primordialmente cosm\u00e9tico:<\/strong> <\/span>Para definir el cumplimiento de este criterio, el grupo tiene en cuenta <strong><span style=\"color: #ffbf00;\">la recuperaci\u00f3n o mantenimiento de la capacidad funcional y vita<\/span>l<\/strong> de los pacientes que reciben la tecnolog\u00eda<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #9b0707;\"><strong>2. Carezcan de evidencia sobre eficacia, seguridad y efectividad cl\u00ednica:<\/strong><\/span> En este punto, el grupo tiene en cuenta la <span style=\"color: #ffbf00;\"><strong>calidad metodol\u00f3gica y el peso<em> de la evidencia<\/em> en los estudios existentes<\/strong><\/span>, o si existe nueva evidencia que demuestre su ineficacia o inferioridad cl\u00ednica frente a otras alternativas<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #9b0707;\"><strong>3. Que no est\u00e9n autorizados para su uso en el pa\u00eds:<\/strong><\/span> Exceptuando los medicamentos considerados por el INVIMA como Vitales No Disponibles y los diferentes usos de medicamentos incluidos dentro del listado de <em>Usos No Incluidos en el Registro Sanitario<\/em> (UNIRS)<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #9b0707;\"><strong>4.Sean experimentales o tengan que ser prestados en el exterior:<\/strong> <\/span>Exceptuando los estudios de laboratorio y patolog\u00eda, con toma de muestra en el pa\u00eds y procesados en el exterior<\/p>\n<p>&nbsp;<\/p>\n<p>Para conocer m\u00e1s, le recomendamos consulte el documento titulado \u201c<span style=\"color: #9b0707;\"><a style=\"color: #9b0707;\" href=\"http:\/\/www.iets.org.co\/Documents\/Metodologia_para_el_desarrollo_del_estudio_tecnico_de_exclusiones.pdf\" target=\"_blank\" rel=\"noopener\"><strong><em><span style=\"color: #ffbf00;\">Metodolog\u00eda para el desarrollo del estudio t\u00e9cnico de las tecnolog\u00edas que no podr\u00e1n ser financiadas con recursos p\u00fablicos asignados a la salud, en el marco del procedimiento t\u00e9cnico cient\u00edfico y participativo<\/span><\/em><\/strong><\/a><\/span>\u201d publicado por el IETS.<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row css=\u00bb.vc_custom_1533834763111{background-color: #ffffff !important;}\u00bb][vc_column][vc_custom_heading text=\u00bb\u00bfEst\u00e1 en riesgo de caer en la lista de exclusiones? Aqu\u00ed le contamos\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_row_inner content_placement=\u00bbmiddle\u00bb][vc_column_inner width=\u00bb1\/4&#8243;][\/vc_column_inner][vc_column_inner width=\u00bb1\/4&#8243;][vc_single_image image=\u00bb1869&#8243; img_size=\u00bb110&#215;110&#8243; alignment=\u00bbcenter\u00bb&#8230;<\/p>\n","protected":false},"author":19,"featured_media":2190,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[4,6],"tags":[51,36,52,53,54,55,56],"ppma_author":[740],"class_list":["post-700","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-news-sgsss","tag-efectividad-clinica","tag-iets","tag-lista-de-exclusiones","tag-medicamentos","tag-recursos-en-salud","tag-seguridad-clinica","tag-tecnologias"],"taxonomy_info":{"category":[{"value":4,"label":"Blogs Publicados"},{"value":6,"label":"Novedades SGSSS"}],"post_tag":[{"value":51,"label":"efectividad cl\u00ednica"},{"value":36,"label":"IETS"},{"value":52,"label":"lista de exclusiones"},{"value":53,"label":"medicamentos"},{"value":54,"label":"recursos en salud"},{"value":55,"label":"seguridad cl\u00ednica"},{"value":56,"label":"tecnolog\u00edas"}]},"featured_image_src_large":["https:\/\/neuroeconomix.com\/wp-content\/uploads\/2017\/10\/riesgo-lista-de-exclusiones-1024x576.jpg",1024,576,true],"author_info":{"display_name":"NeuroEconomix","author_link":"https:\/\/neuroeconomix.com\/en\/author\/wpnotifs\/"},"comment_info":0,"category_info":[{"term_id":4,"name":"Blogs Publicados","slug":"blog","term_group":0,"term_taxonomy_id":4,"taxonomy":"category","description":"","parent":0,"count":251,"filter":"raw","cat_ID":4,"category_count":251,"category_description":"","cat_name":"Blogs Publicados","category_nicename":"blog","category_parent":0},{"term_id":6,"name":"Novedades SGSSS","slug":"news-sgsss","term_group":0,"term_taxonomy_id":6,"taxonomy":"category","description":"","parent":0,"count":45,"filter":"raw","cat_ID":6,"category_count":45,"category_description":"","cat_name":"Novedades SGSSS","category_nicename":"news-sgsss","category_parent":0}],"tag_info":[{"term_id":51,"name":"efectividad cl\u00ednica","slug":"efectividad-clinica","term_group":0,"term_taxonomy_id":51,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"},{"term_id":36,"name":"IETS","slug":"iets","term_group":0,"term_taxonomy_id":36,"taxonomy":"post_tag","description":"","parent":0,"count":15,"filter":"raw"},{"term_id":52,"name":"lista de exclusiones","slug":"lista-de-exclusiones","term_group":0,"term_taxonomy_id":52,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"},{"term_id":53,"name":"medicamentos","slug":"medicamentos","term_group":0,"term_taxonomy_id":53,"taxonomy":"post_tag","description":"","parent":0,"count":58,"filter":"raw"},{"term_id":54,"name":"recursos en salud","slug":"recursos-en-salud","term_group":0,"term_taxonomy_id":54,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"},{"term_id":55,"name":"seguridad cl\u00ednica","slug":"seguridad-clinica","term_group":0,"term_taxonomy_id":55,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"},{"term_id":56,"name":"tecnolog\u00edas","slug":"tecnologias","term_group":0,"term_taxonomy_id":56,"taxonomy":"post_tag","description":"","parent":0,"count":3,"filter":"raw"}],"authors":[{"term_id":740,"user_id":19,"is_guest":0,"slug":"wpnotifs","display_name":"NeuroEconomix","avatar_url":"https:\/\/neuroeconomix.com\/wp-content\/uploads\/2025\/01\/neuroeconomix-home-testimonials.svg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/posts\/700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/comments?post=700"}],"version-history":[{"count":1,"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/posts\/700\/revisions"}],"predecessor-version":[{"id":14446,"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/posts\/700\/revisions\/14446"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/media\/2190"}],"wp:attachment":[{"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/media?parent=700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/categories?post=700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/tags?post=700"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/neuroeconomix.com\/en\/wp-json\/wp\/v2\/ppma_author?post=700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}